Automate Your Wheel Strategy on MCK
With Tiblio's Option Bot, you can configure your own wheel strategy including MCK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MCK
- Rev/Share 3023.1785
- Book/Share -6.9095
- PB -47.6315
- Debt/Equity -5.0498
- CurrentRatio 0.8829
- ROIC 0.1716
- MktCap 93304464721.0
- FreeCF/Share 45.9888
- PFCF 16.2438
- PE 29.6116
- Debt/Assets 0.1222
- DivYield 0.0039
- ROE -1.2479
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | MCK | Mizuho | -- | Neutral | -- | $630 | Dec. 4, 2024 |
| Downgrade | MCK | Robert W. Baird | Outperform | Neutral | $603 | $531 | Sept. 24, 2024 |
| Reiterated | MCK | Leerink Partners | -- | Outperform | $670 | $665 | Sept. 5, 2024 |
News
McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Positive
MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.
Read More
How to trade the health care break out
Published: October 06, 2025 by: CNBC Television
Sentiment: Positive
The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.
Read More
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read More
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Drug distributor McKesson to restructure segments to focus on high-margin businesses
Published: September 18, 2025 by: Reuters
Sentiment: Positive
McKesson said on Thursday it will restructure its operations into four main segments from the current quarter as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.
Read More
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Published: September 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Read More
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Read More
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Negative
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Read More
Here's Why McKesson (MCK) is a Strong Value Stock
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.
Read More
Disney & 3 Other Stocks With Strong Interest Coverage to Buy Now
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
DIS, BJ, RL, and MCK stand out with strong interest coverage ratios, making them attractive picks in a volatile market.
Read More
Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
Evaluate the expected performance of McKesson (MCK) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read More
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Are Medical Stocks Lagging McKesson (MCK) This Year?
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.
Read More
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
Here's Why McKesson (MCK) is a Strong Value Stock
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Read More
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
Published: July 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Here's Why McKesson (MCK) is a Strong Growth Stock
Published: July 03, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
McKesson (MCK) closed at $705.45 in the latest trading session, marking a -3.06% move from the prior day.
Read More
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
These women-run company stocks offer high growth and stability.
Read More
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: July 01, 2025 by: Zacks Investment Research
Sentiment: Positive
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
Read More
About McKesson Corporation (MCK)
- IPO Date 1994-11-10
- Website https://www.mckesson.com
- Industry Medical - Distribution
- CEO Brian S. Tyler
- Employees 44000